Cited by 2,381Blood Pressure and Hypertension StudiesSodium Intake and HealthCardiovascular Health and Risk Factors

Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

Open access
Forouzanfar, Mohammad H., Liu, Patrick, Roth, Gregory A., Ng, Marie, Biryukov, Stan, Marczak, Laurie, Alexander, Lily, Estep, Kara +67 more·2017·JAMA

Abstract

Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. Main Outcomes and Measures: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year. Results: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. Conclusions and Relevance: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2016.19043

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over 50% of heart disease, stroke, and heart failure are caused by increased blood pressure.

    “Over 50% of heart disease, stroke, and heart failure are caused by increased blood pressure.”
  • Hypertension causes over 40% of deaths in people with diabetes and is also a leading risk for fetal and maternal death in pregnancy, dementia, and renal failure (particularly in people of African ancestry) and can cause blindness.

    “Hypertension causes over 40% of deaths in people with dia -betes 11 and is also a leading risk for fetal and maternal death in pregnancy, dementia, and renal failure (particularly in people of African ancestry) and can cause blindness.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Wright JT Jr, Bakris G, Greene T, et al; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA. 2002;288(19):2421-2431.
  2. Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors. Lancet. 1997;349(9063):1436-1442.
  3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010. Lancet. 2012;380 (9859):2224-2260.
  4. Piper MA, Evans CV, Burda BU, et al. Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD). US: Agency for Healthcare Research and Quality; 2014. http://www .ncbi.nlm.nih.gov/books/NBK269495/. Accessed December 17, 2015.

Cited by

Sorted by citations

Authors
Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., Ali, R., Alvis-Guzman, N., Azzopardi, P., Banerjee, A., Bärnighausen, T., Basu, A., Bekele, T., Bennett, D. A., Biadgilign, S., Catalá-López, F., Feigin, V. L., Fernandes, J. C., Fischer, F., Gebru, A. A., Gona, P., Gupta, R., Hankey, G. J., Jonas, J. B., Judd, S. E., Khang, Y.-H., Khosravi, A., Kim, Y. J., Kimokoti, R. W., Kokubo, Y., Kolte, D., Lopez, A., Lotufo, P. A., Malekzadeh, R., Melaku, Y. A., Mensah, G. A., Misganaw, A., Mokdad, A. H., Moran, A. E., Nawaz, H., Neal, B., Ngalesoni, F. N., Ohkubo, T., Pourmalek, F., Rafay, A., Rai, R. K., Rojas-Rueda, D., Sampson, U. K., Santos, I. S., Sawhney, M., Schutte, A. E., Sepanlou, S. G., Shifa, G. T., Shiue, I., Tedla, B. A., Thrift, A. G., Tonelli, M., Truelsen, T., Tsilimparis, N., Ukwaja, K. N., Uthman, O. A., Vasankari, T., Venketasubramanian, N., Vlassov, V. V., Vos, T., Westerman, R., Yan, L. L., Yano, Y., Yonemoto, N., Zaki, M. E. S., & Murray, C. J. L.
Affiliations
  • University of Washington (US)
  • Jimma University, Jimma, Ethiopia
  • University of Alabama at Birmingham (US)
  • University of Oxford (GB)
  • Universidad de Cartagena, Cartagena de Indias, Colombia
  • South Australian Health and Medical Research Institute (AU)
  • Farr Institute (GB)
  • Harvard University (US)
  • University of Canterbury (NZ)
  • Madda Walabu University (ET)
  • Independent Public Health Consultants, Addis Ababa, Ethiopia
  • Universitat de València (ES)
  • Auckland University of Technology (NZ)
  • Pharmacology and Experimental Therapeutics, IBILI - Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Bielefeld University (DE)
  • Mekelle University (ET)
  • University of Massachusetts Boston (US)
  • Eternal Hospital (IN)
  • The University of Western Australia (AU)
  • Heidelberg University (DE)
  • Seoul National University (KR)
  • Ministry of Health and Medical Education (IR)
  • Southern University College (MY)
  • Simmons University (US)
  • National Cerebral and Cardiovascular Center (JP)
  • Brown University (US)
  • University of Melbourne, Melbourne School of Population and Global Health, Melbourne, QLD, Australia
  • Universidade de São Paulo (BR)
  • Digestive Disease Research Institute (IR)
  • The University of Adelaide (AU)
  • National Institutes of Health (US)
  • Columbia University (US)
  • SIU Medicine (US)
  • The University of Sydney (AU)
  • Ministry of Health and Social Welfare (TZ)
  • Teikyo University (JP)
  • University of British Columbia (CA)
  • Contech School of Public Health, Lahore, Punjab, Pakistan
  • Society for Health and Demographic Surveillance, Suri, India
  • ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
  • Marshall University (US)
  • South African Medical Research Council (ZA)
  • Southern Nations, Nationalities, and Peoples' Region (ET)
  • Northumbria University (GB)
  • James Cook University (AU)
  • Monash Health (AU)
  • University of Calgary (CA)
  • University of Copenhagen (DK)
  • Universität Hamburg (DE)
  • Federal Teaching Hospital Abakaliki (NG)
  • University of Warwick (GB)
  • Urho Kaleva Kekkonen Institute (FI)
  • Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore
  • National Research University Higher School of Economics, Moscow, Russia
  • Federal Institute for Population Research (DE)
  • Duke Kunshan University (CN)
  • Northwestern University (US)
  • National Center of Neurology and Psychiatry (JP)
  • Mansoura University (EG)
Corresponding author
Murray, Christopher J. L.
Venue
JAMA
Published
2017-01-10
Volume
317
Issue
2
Pages
165
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2572331255
Cited by
2,381
References
56
Citations by year
2026: 120 · 2025: 186 · 2024: 280 · 2023: 329 · 2022: 323 · 2021: 320 · 2020: 308 · 2019: 264 · 2018: 166 · 2017: 78 · 2016: 2
FWCI
172.71
Type
journal article
Language
en
Open access
Locations
  • JAMA (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
  • ResearchOnline at James Cook University (James Cook University) (submittedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
  • UCL Discovery (University College London) (submittedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Northumbria Research Link (Northumbria University) (submittedVersion)
  • PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
  • Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • Bill and Melinda Gates Foundation
  • Omron Healthcare
  • National Institute for Health and Care Research (CL-2010-09-002)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords
hypertension, systolic blood pressure, global burden of disease, ischemic heart disease, ischemic stroke, hemorrhagic stroke, disability-adjusted life years, cause-specific mortality, cardiovascular disease, health loss, age and sex differences, spatiotemporal trends, cardiovascular risk factors, 1990-2015 trends
MeSH terms
Adult, Aged, Aged, 80 and over, Blood Pressure, Cause of Death, Female, Health Surveys, Humans, Hypertension, Male, Middle Aged, Monte Carlo Method, Systole, Global Health, Prevalence, Normal Distribution, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Quality-Adjusted Life Years, Intracranial Hemorrhages, Stroke, Uncertainty, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review